Next earnings date: 8 Sep 2025

Avid Bioservices, Inc. – NASDAQ:CDMO

Add to watchlist

$12.5

+0.25

+2.12%

Market closed

Open in 2 days

+47.12%

month

+47.12%

quarter

+81.33%

year

Market Cap	785.46M
Enterprise value	1.38B

P/E	11.45
EV/Sales	9.84
EV/EBITDA	122.77
Price/Sales	8.98
Price/Book	6.82
PEG ratio	N/A
EPS	-2.03

Revenue	154.60M
EBITDA	6.76M
Income	-128.95M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	82.78%
Oper. margin	2.73%
Gross margin	21.37%
EBIT margin	2.73%
EBITDA margin	4.38%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Avid Bioservices, Inc. (NASDAQ:CDMO): Profit margin
Jan 2023	38.01M	461K	1.21%
Apr 2023	39.79M	-309K	-0.78%
Jan 2024	33.81M	-6.00M	-17.76%
Apr 2024	42.97M	-123.10M	-286.45%

Avid Bioservices Financials Estimate

Q Y

Avid Bioservices, Inc. (NASDAQ:CDMO): Analyst Estimates
Oct 2025	41.05M	-3.79M	-9.25%
Jan 2026	47.10M	633.21K	1.34%
Apr 2026	54.54M	3.16M	5.8%
May 2026	59.30M	5.05M	8.52%

Analysts Price target
Financials & Ratios estimates

Avid Bioservices, Inc. (NASDAQ:CDMO): Earnings per share (EPS)
2024-09-09	-0.01833	-0.03

Avid Bioservices, Inc. (NASDAQ:CDMO): Payout ratio
Payout ratio	0%

Avid Bioservices, Inc. (NASDAQ:CDMO): Dividend Yield
2020	1.26%
2021	0.36%
2022
2023
2024

Avid Bioservices, Inc. (NASDAQ:CDMO): Debt to assets
Jan 2023	450430000	265.03M	58.84%
Apr 2023	451054000	261.58M	57.99%
Jan 2024	455227000	275.05M	60.42%
Apr 2024	336557000	275.66M	81.91%

Avid Bioservices, Inc. (NASDAQ:CDMO): Cash Flow
Jan 2023	-6.91M	-11.32M	868K
Apr 2023	2.79M	-24.87M	704K
Jan 2024	3.68M	-4.48M	85K
Apr 2024	1.25M	-5.69M	11.83M

Avid Bioservices alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Avid Bioservices, Inc. (NASDAQ:CDMO): Employee count
Aug 2023	365
Sep 2023	365
Oct 2023	365
Nov 2023	365
Dec 2023	365
Jan 2024	365
Feb 2024	365
Mar 2024	365
Apr 2024	365
May 2024	365
Jun 2024	365
Jul 2024	365

Avid Bioservices
Hedge Funds Holdings Q3 2022

93.44% +7.09%

of CDMO is owned by hedge funds

160 -20

hedge funds hold CDMO stock

59.17M -1.67M

shares is hold by hedge funds

CDMO hedge funds holdings changes

Avid Bioservices
Insider Trading

Avid Bioservices, Inc. (NASDAQ:CDMO): Insider trades (number of shares)
Period	Buy	Sel
Jan 2024	0	6259
Apr 2024	0	18578
Jul 2024	0	10641
Dec 2024	0	412610

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	26 Dec 2024	KWIETNIAK MATTHEW R. officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock, $0.001 par value	3,225	$12.22	$39,410
Sale	26 Dec 2024	GREEN NICHOLAS STEWART director, officer: President & CEO director, officer: President & ..	Common Stock, $0.001 par value	57,675	$12.22	$704,789
Sale	26 Dec 2024	RICHIERI RICHARD A. officer: Chief Operations Officer officer: Chief Operations Officer	Common Stock, $0.001 par value	3,843	$12.22	$46,961
Sale	26 Dec 2024	KWIETNIAK MATTHEW R. officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock, $0.001 par value	10,165	$12.22	$124,216
Sale	26 Dec 2024	HART DANIEL R officer: Chief Fi..	Common Stock, $0.001 par value	1,968	$12.22	$24,049
Sale	26 Dec 2024	HART DANIEL R officer: Chief Fi..	Common Stock, $0.001 par value	20,845	$12.22	$254,726
Sale	26 Dec 2024	GREEN NICHOLAS STEWART director, officer: President & CEO director, officer: President & ..	Common Stock, $0.001 par value	88,236	$12.22	$1,078,244
Option	25 Dec 2024	RICHIERI RICHARD A. officer: Chief Operations Officer officer: Chief Operations Officer	Common Stock, $0.001 par value	10,695	N/A	N/A
Option	25 Dec 2024	KWIETNIAK MATTHEW R. officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock, $0.001 par value	29,479	N/A	N/A
Option	25 Dec 2024	KWIETNIAK MATTHEW R. officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock, $0.001 par value	9,300	N/A	N/A

CDMO insider trading transactions

Avid Bioservices
Earnings Call Transcripts

Quarter	Transcript
Q3 2024 29 Apr 2024	Q3 2024 Earnings Call Transcript
Q2 2024 7 Dec 2023	Q2 2024 Earnings Call Transcript
Q1 2024 7 Sep 2023	Q1 2024 Earnings Call Transcript
Q4 2023 21 Jun 2023	Q4 2023 Earnings Call Transcript

CDMO earnings call transcripts

Avid Bioservices
Executives

Insider	Age	Compensation
Mr. Nicholas Stewart Green B.Sc., MBA (1965) Pres, Chief Executive Officer & Director	60	$1,550,000
Mr. Daniel R. Hart (1973) Chief Financial Officer	52	$899,280
Mr. Mark R. Ziebell J.D. (1964) Vice President, Gen. Counsel & Corporation Sec.	61	$707,750

Avid Bioservices
Latest News

Saturday, 28 December 2024
15:24	CDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to Shareholders	businesswire.com
12:00	Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm	accesswire.com
Friday, 27 December 2024
11:45	The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Avid Bioservices Inc For Securities Fraud	accesswire.com
Thursday, 26 December 2024
12:45	Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm	accesswire.com
10:00	Bronstein, Gewirtz & Grossman, LLC Encourages Avid Bioservices, Inc. (CDMO) Stockholders to Inquire about Securities Investigation	accesswire.com
Tuesday, 24 December 2024
12:45	The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Avid Bioservices Inc For Securities Fraud	accesswire.com
Monday, 23 December 2024
11:30	Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Sunday, 22 December 2024
10:00	Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Investors to Learn More About the Investigation	accesswire.com
Saturday, 21 December 2024
11:15	The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Avid Bioservices Inc For Securities Fraud	accesswire.com
Friday, 20 December 2024
10:30	Avid Bioservices Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Thursday, 19 December 2024
13:15	The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Avid Bioservices Inc. For Securities Fraud	accesswire.com
07:00	Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment	globenewswire.com
Wednesday, 18 December 2024
16:35	Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction	globenewswire.com
13:45	Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm	accesswire.com
10:00	Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Stockholders to Learn More About the Investigation	accesswire.com
Tuesday, 17 December 2024
13:30	The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Avid Bioservices Inc For Possible Securities Fraud	accesswire.com
Monday, 16 December 2024
17:15	Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
09:25	Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.	prnewswire.com
Sunday, 15 December 2024
13:45	The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Avid Bioservices Inc For Securities Fraud	accesswire.com
10:00	Bronstein, Gewirtz & Grossman, LLC Encourages Avid Bioservices, Inc. (CDMO) Investors to Inquire about Securities Investigation	accesswire.com
Saturday, 14 December 2024
13:45	Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Friday, 13 December 2024
18:15	The Schall Law Firm Urges Stockholder Participation In An Inquiry Into Avid Bioservices Inc For Possible Securities Fraud	accesswire.com
Thursday, 12 December 2024
13:45	Avid Bioservices, Inc. Is Being Investigated For Securities Related Infractions And Affected Investors Are Invited To Contact The Schall Law Firm	accesswire.com
Wednesday, 11 December 2024
13:30	The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Avid Bioservices Inc For Securities Fraud	accesswire.com
10:00	Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avid Bioservices, Inc. (CDMO) And Encourages Investors to Reach Out	accesswire.com
Tuesday, 10 December 2024
17:15	Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Invited To Contact The Schall Law Firm	accesswire.com
16:05	Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024	globenewswire.com
Monday, 9 December 2024
17:30	The Schall Law Firm Encourages Stockholder Contributions To An Inquiry Into Avid Bioservices Inc's Possible Securities Fraud	accesswire.com
Sunday, 8 December 2024
18:30	Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Reach Out To The Schall Law Firm	accesswire.com
10:00	Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avid Bioservices, Inc. (CDMO) And Encourages Stockholders to Reach Out	accesswire.com

Ideas & Opinions

Seeking Alpha 16 May 2024

Avid Bioservices: A Unique Growth Story With Many Tailwinds And Catalysts
Seeking Alpha 7 Jan 2024

Avid Bioservices: Don't Miss The Bigger Picture
Seeking Alpha 20 May 2023

Avid Bioservices Bolsters Manufacturing Capabilities And Generates High-Demand Services
Seeking Alpha 20 Apr 2023

Lifecore: Extraordinary Upside Likely Despite Bankruptcy Concerns
Seeking Alpha 9 Dec 2022

Avid Bioservices: Production Expansion Capex And High Costs Are Temporary Issues
Seeking Alpha 1 Aug 2022

5 Real Growth 'Strong Buys'
Seeking Alpha 16 Jun 2022

Lonza: One Stop Shop For Global Drug Manufacturing, At A Price
Seeking Alpha 29 Jan 2022

Avid Bioservices Expands Production Capacity To Continue Growth Trajectory
Seeking Alpha 11 Aug 2021

Avid Bioservices: FDA CGMP Stringency Provides Stable Long Outlook
Seeking Alpha 27 Apr 2021

3 Healthcare Stocks As The Sector Breaks Out To New Highs

Frequently Asked Questions (FAQ)

What's the price of Avid Bioservices stock today?

One share of Avid Bioservices stock can currently be purchased for approximately $12.5.
When is Avid Bioservices's next earnings date?

Avid Bioservices, Inc. is estimated to report earnings on Monday, 8 Sep 2025.
Does Avid Bioservices pay dividends?

No, Avid Bioservices does not pay dividends.
How much money does Avid Bioservices make?

Avid Bioservices has a market capitalization of 785.46M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6.27% to 139.91M US dollars. Avid Bioservices made a loss 140.75M US dollars in net income (profit) last year or -$0.03 on an earnings per share basis.
What is Avid Bioservices's stock symbol?

Avid Bioservices, Inc. is traded on the NASDAQ under the ticker symbol "CDMO".
What is Avid Bioservices's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Avid Bioservices?

Shares of Avid Bioservices can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Avid Bioservices's key executives?
Avid Bioservices's management team includes the following people:
- Mr. Nicholas Stewart Green B.Sc., MBA Pres, Chief Executive Officer & Director(age: 60, pay: $1,550,000)
- Mr. Daniel R. Hart Chief Financial Officer(age: 52, pay: $899,280)
- Mr. Mark R. Ziebell J.D. Vice President, Gen. Counsel & Corporation Sec.(age: 61, pay: $707,750)
How many employees does Avid Bioservices have?

As Jul 2024, Avid Bioservices employs 365 workers.
When Avid Bioservices went public?

Avid Bioservices, Inc. is publicly traded company for more then 31 years since IPO on 4 Apr 1994.
What is Avid Bioservices's official website?

The official website for Avid Bioservices is avidbio.com.
Where are Avid Bioservices's headquarters?

Avid Bioservices is headquartered at 2642 Michelle Drive, Tustin, CA.
How can i contact Avid Bioservices?

Avid Bioservices's mailing address is 2642 Michelle Drive, Tustin, CA and company can be reached via phone at +7 145086100.

Avid Bioservices, Inc.

avidbio.com

Exchange:

NASDAQ

Full time employees:

371

Industry:

Biotechnology

Sector:

Healthcare

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

+7 145086100

2642 Michelle Drive
Tustin, CA 92780

CIK: 0000704562
ISIN: US05368M1062
CUSIP: 05368M106